Trial Outcomes & Findings for Smartphone-Administered App Treatment for Adults With Body Dysmorphic Disorder (NCT NCT03221738)

NCT ID: NCT03221738

Last Updated: 2019-06-26

Results Overview

Number of subjects who completed the app-based treatment to assess feasibility and acceptability

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

10 participants

Primary outcome timeframe

Post treatment assessment (12 weeks)

Results posted on

2019-06-26

Participant Flow

Participant milestones

Participant milestones
Measure
App-Based Cognitive Behavioral Therapy
12-week Smartphone-delivered CBT for BDD. App-Based Cognitive Behavioral Therapy: 12-week Smartphone delivered CBT for BDD. In-person cognitive behavioral therapy (CBT) is an empirically supported treatment for BDD. The app-delivered CBT in this project includes modules such as cognitive skills (e.g., cognitive restructuring, core belief work), behavioral skills (e.g., exposure with ritual prevention), and perceptual retraining/mindfulness skills.
Overall Study
STARTED
10
Overall Study
COMPLETED
10
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Smartphone-Administered App Treatment for Adults With Body Dysmorphic Disorder

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
App-Based Cognitive Behavioral Therapy
n=10 Participants
12-week Smartphone-delivered CBT for BDD. App-Based Cognitive Behavioral Therapy: 12-week Smartphone delivered CBT for BDD. In-person cognitive behavioral therapy (CBT) is an empirically supported treatment for BDD. The app-delivered CBT in this project includes modules such as cognitive skills (e.g., cognitive restructuring, core belief work), behavioral skills (e.g., exposure with ritual prevention), and perceptual retraining/mindfulness skills.
Age, Continuous
27.6 years
STANDARD_DEVIATION 5.66 • n=93 Participants
Sex: Female, Male
Female
8 Participants
n=93 Participants
Sex: Female, Male
Male
2 Participants
n=93 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=93 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants
n=93 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=93 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=93 Participants
Race (NIH/OMB)
Asian
0 Participants
n=93 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=93 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=93 Participants
Race (NIH/OMB)
White
8 Participants
n=93 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=93 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=93 Participants

PRIMARY outcome

Timeframe: Post treatment assessment (12 weeks)

Number of subjects who completed the app-based treatment to assess feasibility and acceptability

Outcome measures

Outcome measures
Measure
App-Based Cognitive Behavioral Therapy
n=10 Participants
12-week Smartphone-delivered CBT for BDD. App-Based Cognitive Behavioral Therapy: 12-week Smartphone delivered CBT for BDD. In-person cognitive behavioral therapy (CBT) is an empirically supported treatment for BDD. The app-delivered CBT in this project includes modules such as cognitive skills (e.g., cognitive restructuring, core belief work), behavioral skills (e.g., exposure with ritual prevention), and perceptual retraining/mindfulness skills.
Treatment Completion Rates
10 Participants

PRIMARY outcome

Timeframe: Post-treatment assessment (week 12)

The Client Satisfaction Questionnaire (CSQ) is a 25-item self-report questionnaire which assesses the satisfaction with clinical services received. Total scores range from 8 to 32, with the higher number indicating greater satisfaction.

Outcome measures

Outcome measures
Measure
App-Based Cognitive Behavioral Therapy
n=10 Participants
12-week Smartphone-delivered CBT for BDD. App-Based Cognitive Behavioral Therapy: 12-week Smartphone delivered CBT for BDD. In-person cognitive behavioral therapy (CBT) is an empirically supported treatment for BDD. The app-delivered CBT in this project includes modules such as cognitive skills (e.g., cognitive restructuring, core belief work), behavioral skills (e.g., exposure with ritual prevention), and perceptual retraining/mindfulness skills.
Client Satisfaction Questionnaire (CSQ). This Measure Will be Used to Assess Change Over the Course of Treatment Twice Throughout the Study (Over Approximately 10 Months Total).
27.90 score on a scale
Standard Deviation 3.51

SECONDARY outcome

Timeframe: Post-treatment assessment (week 12)

The BDD-YBOCS is the gold-standard, semi-structured clinician-administered assessment of BDD severity. It contains 12 items ranging from 0 to 4, which are summed to generate a total score (range = 0 to 48). Higher scores indicate more severe BDD symptoms. The BDD-YBOCS will be used to assess change in BDD symptoms from baseline to endpoint.

Outcome measures

Outcome measures
Measure
App-Based Cognitive Behavioral Therapy
n=10 Participants
12-week Smartphone-delivered CBT for BDD. App-Based Cognitive Behavioral Therapy: 12-week Smartphone delivered CBT for BDD. In-person cognitive behavioral therapy (CBT) is an empirically supported treatment for BDD. The app-delivered CBT in this project includes modules such as cognitive skills (e.g., cognitive restructuring, core belief work), behavioral skills (e.g., exposure with ritual prevention), and perceptual retraining/mindfulness skills.
Yale Brown Obsessive Compulsive Scale Modified for BDD (BDD-YBOCS). This Measure Will be Used to Assess Change Over the Course of Treatment at Five Time Points Throughout the Study (Over Approximately 10 Months Total).
16.50 score on a scale
Standard Deviation 3.63

Adverse Events

App-Based Cognitive Behavioral Therapy

Serious events: 0 serious events
Other events: 6 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
App-Based Cognitive Behavioral Therapy
n=10 participants at risk
12-week Smartphone-delivered CBT for BDD. App-Based Cognitive Behavioral Therapy: 12-week Smartphone delivered CBT for BDD. In-person cognitive behavioral therapy (CBT) is an empirically supported treatment for BDD. The app-delivered CBT in this project includes modules such as cognitive skills (e.g., cognitive restructuring, core belief work), behavioral skills (e.g., exposure with ritual prevention), and perceptual retraining/mindfulness skills.
Infections and infestations
Urinary tract infection
10.0%
1/10 • Number of events 1 • Adverse event data were collected at mid-treatment (6 weeks), post-treatment (12 weeks), 3-month and 6-month follow-up assessment time-points.
Psychiatric disorders
Depressive symptoms
30.0%
3/10 • Number of events 3 • Adverse event data were collected at mid-treatment (6 weeks), post-treatment (12 weeks), 3-month and 6-month follow-up assessment time-points.
Reproductive system and breast disorders
Pap smear
12.5%
1/8 • Number of events 1 • Adverse event data were collected at mid-treatment (6 weeks), post-treatment (12 weeks), 3-month and 6-month follow-up assessment time-points.
Reproductive system and breast disorders
Delayed menstrual cycle
12.5%
1/8 • Number of events 1 • Adverse event data were collected at mid-treatment (6 weeks), post-treatment (12 weeks), 3-month and 6-month follow-up assessment time-points.
Psychiatric disorders
Increased stress/anxiety
20.0%
2/10 • Number of events 3 • Adverse event data were collected at mid-treatment (6 weeks), post-treatment (12 weeks), 3-month and 6-month follow-up assessment time-points.
Reproductive system and breast disorders
Breast lump examination
10.0%
1/10 • Number of events 1 • Adverse event data were collected at mid-treatment (6 weeks), post-treatment (12 weeks), 3-month and 6-month follow-up assessment time-points.
General disorders
Wisdom teeth removal
10.0%
1/10 • Number of events 1 • Adverse event data were collected at mid-treatment (6 weeks), post-treatment (12 weeks), 3-month and 6-month follow-up assessment time-points.

Additional Information

Anna Schwartzberg

Massachusetts General Hospital

Phone: 617-724-7161

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place